These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients. Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928 [TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of immunosuppression and cellular rejection on cardiac allograft vasculopathy: time for a reappraisal. Mehra MR; Ventura HO; Chambers RB; Ramireddy K; Smart FW; Stapleton DD J Heart Lung Transplant; 1997 Jul; 16(7):743-51. PubMed ID: 9257256 [TBL] [Abstract][Full Text] [Related]
4. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789 [TBL] [Abstract][Full Text] [Related]
5. Lack of progressive "restrictive" physiology after heart transplantation despite intervening episodes of allograft rejection: comparison of serial rest and exercise hemodynamics one and two years after transplantation. Hosenpud JD; Pantely GA; Morton MJ; Wilson RA; Norman DJ; Cobanoglu AM; Starr A J Heart Transplant; 1990; 9(2):119-23. PubMed ID: 2319369 [TBL] [Abstract][Full Text] [Related]
13. Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation. Brunner-La Rocca HP; Sütsch G; Schneider J; Follath F; Kiowski W Circulation; 1996 Sep; 94(6):1334-8. PubMed ID: 8822989 [TBL] [Abstract][Full Text] [Related]
14. Usefulness of the combined index of systolic and diastolic myocardial performance to identify cardiac allograft rejection. Vivekananthan K; Kalapura T; Mehra M; Lavie C; Milani R; Scott R; Park M Am J Cardiol; 2002 Sep; 90(5):517-20. PubMed ID: 12208413 [TBL] [Abstract][Full Text] [Related]
15. Formation of the inflammasome during cardiac allograft rejection. Shah KB; Mauro AG; Flattery M; Toldo S; Abbate A Int J Cardiol; 2015 Dec; 201():328-30. PubMed ID: 26301674 [No Abstract] [Full Text] [Related]
16. Association between blood eosinophil counts and acute cardiac and pulmonary allograft rejection. Trull A; Steel L; Cornelissen J; Smith T; Sharples L; Cary N; Stewart S; Large S; Wallwork J J Heart Lung Transplant; 1998 May; 17(5):517-24. PubMed ID: 9628572 [TBL] [Abstract][Full Text] [Related]
18. HLA-DR mismatching correlates with early cardiac allograft rejection, incidence, and graft survival when high-confidence-level serological DR typing is used. De Mattos AM; Head MA; Everett J; Hosenpud J; Hershberger R; Cobanoglu A; Ott G; Ratkovec R; Norman DJ Transplantation; 1994 Feb; 57(4):626-30. PubMed ID: 8116051 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection. Karason K; Jernås M; Hägg DA; Svensson PA BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603 [TBL] [Abstract][Full Text] [Related]